Remote technology has quickly become a critical element of clinical trials. According to a June 2021 survey from WCG, 94% of research sites expect to use at least one form of remote technology in the ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

There is a growing interest within the medical community in the use of psychedelic therapies to treat conditions ranging from ...

Phase I trials often represent the first occasion where new cancer strategies are tested in patients. Various developments in cancer biology, methodology, regulation, and medical ethics have altered ...

The second half of 2022 brought the first gene therapies for hemophilia to the market in both the United States and abroad. The second half of 2022 brought the first gene therapies for hemophilia to ...

An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

With the recent advances in cell reprogramming, scientists can take a mature human cell — such as a skin cell — and revert it to an immature, pluripotent state that can become almost any cell type in ...

Oriel Zagazeta is a biology major with a chemistry minor and is a 2022-23 health care ethics intern at the Markkula Center for Applied Ethics. Views are his own. The use of stem cells in health care ...

Unlike traditional treatments, nanoparticles (NPs) are highly precise in targeting diseased cells at the molecular level, enhancing the effectiveness of treatments for conditions like cancer, diabetes ...